Especially, Mr Wang Jin-Pyng, spokesperson of the Legislative Yuan, and Mr Sean Chen, premier of the Executive Yuan, in August announced the 33 policy guidelines on biopharmaceutical industry promotion and set out an explicit timetable for the reform of new drug development and the BNHI pricing policy. These actions inspire the industry's confidence. This cooperation project is indeed a showcase for the Executive Yuan's "Taiwan Biotech Take-off Diamond Action Plan".

Mr Ichiro Nakatomi, President of NanoCarrier, highlighted the Taiwanese government TFDA and IDB have come up with a new policy to provide necessary support and assistance for a domestic company contributing to the research development of a innovative pharmaceutical product by helping them quickly obtain drug licenses and drug prices. This policy will contribute to the success of new drug R&D in Taiwan.